Review of Metabolic Efficiency of Sleeve Gastrectomy

English (OpenAlex)

Background: Sleeve gastrectomy (SG) is currently the most widely performed operation for treatment of morbid obesity. SG leads to significant weight loss and reduction in weight-related comorbidities. This study aimed to evaluate the effects of laparoscopic sleeve gastrectomy (LSG) on the metabolism of patients with obesity. Methods: The cases of patients who underwent LSG were reviewed for preoperative medical history, comorbidities, medications, routine preoperative work-up, perioperative outcomes, and postoperative follow-up at months 1, 3, and 6 and years 1 and 2. Body mass index and excess weight loss decreases, comorbidity status, and medication requirements were evaluated. Results: A total of 383 patients who regularly attended their follow-up appointments (76.6%) were analyzed. In the postoperative follow-up of 130 (98.49%) patients with type 2 diabetes (p = 0.001), 107 (89.92%) with hypertension (p = 0.001), 130 (98.49%) with sleep apnea syndrome (p = 0.001), 6 (66.67%) with cardiovascular disease (p = 0.031), 23 (95.83%) with dyslipidemia (p = 0.001), and 41 (82%) with osteoarthritis (p = 0.001), resolution or improvement was observed. Conclusion: The short-term results of SG surgery in terms of weight loss and resolution from comorbidities have become one of the surgical options for cases of obesity.